EE9800295A - Meetod hilineva emeesihoo raviks toimeainete ninakaudse manustamisega - Google Patents

Meetod hilineva emeesihoo raviks toimeainete ninakaudse manustamisega

Info

Publication number
EE9800295A
EE9800295A EE9800295A EE9800295A EE9800295A EE 9800295 A EE9800295 A EE 9800295A EE 9800295 A EE9800295 A EE 9800295A EE 9800295 A EE9800295 A EE 9800295A EE 9800295 A EE9800295 A EE 9800295A
Authority
EE
Estonia
Prior art keywords
intranasally
administering
active agents
delayed emesis
treating delayed
Prior art date
Application number
EE9800295A
Other languages
English (en)
Other versions
EE03665B1 (et
Inventor
Psilogenis Mary
Original Assignee
Ribogene, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribogene, Inc. filed Critical Ribogene, Inc.
Publication of EE9800295A publication Critical patent/EE9800295A/et
Publication of EE03665B1 publication Critical patent/EE03665B1/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
EE9800295A 1996-03-14 1997-03-13 Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks EE03665B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/616,121 US5760086A (en) 1996-03-14 1996-03-14 Nasal administration of agents for treatment of delayed onset emesis
PCT/US1997/003974 WO1997033573A1 (en) 1996-03-14 1997-03-13 Nasal administration of agents for treatment of delayed onset emesis

Publications (2)

Publication Number Publication Date
EE9800295A true EE9800295A (et) 1999-02-15
EE03665B1 EE03665B1 (et) 2002-04-15

Family

ID=24468120

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800295A EE03665B1 (et) 1996-03-14 1997-03-13 Metoklopramiidi ninapihusti formulatsioon kasutamiseks hilineva emeesi ärahoidmiseks

Country Status (24)

Country Link
US (1) US5760086A (et)
EP (1) EP0891186B1 (et)
JP (1) JP2000507234A (et)
KR (1) KR100420673B1 (et)
CN (1) CN1217657A (et)
AT (1) ATE489137T1 (et)
AU (1) AU707467B2 (et)
BG (1) BG102780A (et)
CA (1) CA2248968C (et)
CZ (1) CZ289797B6 (et)
DE (1) DE69740060D1 (et)
DK (1) DK0891186T3 (et)
EE (1) EE03665B1 (et)
ES (1) ES2357520T3 (et)
IL (1) IL126199A (et)
NO (1) NO984245L (et)
NZ (1) NZ331991A (et)
PL (1) PL328940A1 (et)
PT (1) PT891186E (et)
RU (1) RU2181588C2 (et)
SK (1) SK282695B6 (et)
UA (1) UA57733C2 (et)
WO (1) WO1997033573A1 (et)
YU (1) YU40398A (et)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6770262B2 (en) 2000-03-30 2004-08-03 Questcor Pharmaceuticals, Inc. Nasal administration of agents for the treatment of gastroparesis
RU2344813C1 (ru) * 2007-04-26 2009-01-27 Федеральное государственное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова Федерального агентства по здравоохранению и социальному развитию Способ предупреждения послеоперационной тошноты и рвоты у детей
CN102209470B (zh) * 2008-11-11 2013-03-13 荷兰联合利华有限公司 茶组合物
US20130213393A1 (en) 2009-12-22 2013-08-22 Evoke Pharma, Inc. Nasal formulations of metoclopramide
DK2376075T3 (en) * 2008-12-22 2015-05-26 Evoke Pharma Inc Nasal formulations of metoclopramide
US20110165143A1 (en) * 2010-01-06 2011-07-07 The Regents Of The University Of Colorado, A Body Corporate Modulation of caspases and therapeutical applications
PL2747561T3 (pl) 2011-08-25 2018-11-30 Evoke Pharma, Inc. Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej
FR2980976B1 (fr) * 2011-10-10 2015-10-16 Mohamed Skiba Composition pharmaceutique pour l'administration par voie nasale de la metopimazine
CN104606136A (zh) * 2015-01-06 2015-05-13 中国人民解放军军事医学科学院毒物药物研究所 甲氧氯普胺鼻腔喷雾剂、其制备方法及用途
WO2018112061A1 (en) 2016-12-15 2018-06-21 Evoke Pharma, Inc. Treatment of moderate and severe gastroparesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412585D0 (en) * 1984-05-17 1984-06-20 Beecham Group Plc Composition
US4624965A (en) * 1984-11-15 1986-11-25 Nastech Pharmaceutical Co., Inc. Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same
DE4131276B4 (de) * 1990-09-28 2007-07-19 Solvay Pharmaceuticals Gmbh Peroral applizierbare Metoclopramidlösungen

Also Published As

Publication number Publication date
WO1997033573A1 (en) 1997-09-18
CA2248968A1 (en) 1997-09-18
NZ331991A (en) 2000-04-28
IL126199A0 (en) 1999-05-09
KR19990087763A (ko) 1999-12-27
YU40398A (sh) 2001-07-10
PL328940A1 (en) 1999-03-01
EP0891186A1 (en) 1999-01-20
CZ289797B6 (cs) 2002-04-17
CZ292298A3 (cs) 1999-03-17
EP0891186A4 (en) 2004-03-31
US5760086A (en) 1998-06-02
UA57733C2 (uk) 2003-07-15
DE69740060D1 (de) 2011-01-05
ES2357520T3 (es) 2011-04-27
DK0891186T3 (da) 2011-03-14
EE03665B1 (et) 2002-04-15
CA2248968C (en) 2005-08-02
AU707467B2 (en) 1999-07-08
BG102780A (en) 2000-01-31
ATE489137T1 (de) 2010-12-15
IL126199A (en) 2004-06-01
NO984245D0 (no) 1998-09-14
KR100420673B1 (ko) 2004-07-23
PT891186E (pt) 2011-02-25
JP2000507234A (ja) 2000-06-13
SK125998A3 (en) 1999-03-12
EP0891186B1 (en) 2010-11-24
CN1217657A (zh) 1999-05-26
RU2181588C2 (ru) 2002-04-27
NO984245L (no) 1998-11-11
SK282695B6 (sk) 2002-11-06
AU2210297A (en) 1997-10-01

Similar Documents

Publication Publication Date Title
ES2174843T3 (es) Agentes antifungicos peptidicos ciclicos y procedimiento para su preparacion.
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
DE50010931D1 (de) Substituierte benzimidazole
ATE134155T1 (de) Stickoxidreduktion mittels eines harnstoffhydrolysats
EA199700170A1 (ru) Способ получения некоторых азациклогексапетидов
SE9502893L (sv) Användning av kollagenas
EE9800295A (et) Meetod hilineva emeesihoo raviks toimeainete ninakaudse manustamisega
ATE226014T1 (de) Prophylaktische behandlung der allergischen kontaktdermatitis
ATE226084T1 (de) Wundheilung und behandlung von fibrose
ES2121109T3 (es) Composicion de champu.
MX9804589A (es) Composiciones blanqueadoras para aspersion, con irritacion respiratoria reducida.
DE69917445D1 (de) Reinigung von carboxaldehyd
ES2180643T3 (es) Procedimiento para tratar la disfuncion cognitiva.
EA200100501A1 (ru) Схема обезболивания
DK0625969T3 (da) Arylalkoxyphenoxyimidazolinforbindelser
EA199900174A1 (ru) Способ лечения биполярного расстройства
NO954115L (no) Anvendelse av ceruletid-dietylaminsalt ved behandling av psoriasis
IT1267142B1 (it) Composto attivo complesso atto ad indurre un rafforzamento e rinnovamento della struttura elastica della cute.
MX9909548A (es) Metodos para la reduccion de fibrinogenos.
NO20010171L (no) Teknisk behandling av tåke
MX9804586A (es) Uso de una composicion acida para la suavidad mejorada a la piel.

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20050313